81 related articles for article (PubMed ID: 2063025)
1. [Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine].
García Rojas JF; Mangas Rojas A; Barba Chacón A; García Osle M; Zamora Madaria E
Rev Clin Esp; 1991 Jan; 188(1):37-40. PubMed ID: 2063025
[TBL] [Abstract][Full Text] [Related]
2. Response to neurotransmitter modulating drugs in patients with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Clin Endocrinol (Oxf); 1986 Dec; 25(6):661-7. PubMed ID: 3115630
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
[TBL] [Abstract][Full Text] [Related]
4. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland.
Croughs RJ; Koppeschaar HP; van't Verlaat JW; McNicol AM
J Clin Endocrinol Metab; 1989 Feb; 68(2):495-8. PubMed ID: 2537335
[TBL] [Abstract][Full Text] [Related]
6. Prolonged remission of Cushing's disease following bromocriptine therapy.
McKenna MJ; Linares M; Mellinger RC
Henry Ford Hosp Med J; 1987; 35(4):188-91. PubMed ID: 3329168
[No Abstract] [Full Text] [Related]
7. Cyproheptadine-induced remission of Cushing's disease.
Krieger DT; Amorosa L; Linick F
N Engl J Med; 1975 Oct; 293(18):893-6. PubMed ID: 1177986
[TBL] [Abstract][Full Text] [Related]
8. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
9. Cyproheptadine in the control of Cushing's disease.
Hsu TH; Gann DS; Tsan KW; Russell RP
Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
[TBL] [Abstract][Full Text] [Related]
10. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
[TBL] [Abstract][Full Text] [Related]
11. Cushing's disease. A review.
Burch WM
Arch Intern Med; 1985 Jun; 145(6):1106-11. PubMed ID: 3923962
[TBL] [Abstract][Full Text] [Related]
12. [Unique type of Cushing's disease in clinical profile: cyclic Cushing's syndrome and Cushing's disease with favorable outcome to a high daily dose of bromocriptine].
Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):11-6. PubMed ID: 7958078
[TBL] [Abstract][Full Text] [Related]
13. Fever of unexplained origin, biochemical Cushing's disease and cerebral dysrhythmia corrected by valproate sodium.
López-Moreno JM; Rodríguez-Portales JA; Mahana D
Can Med Assoc J; 1985 Jan; 132(2):150-4. PubMed ID: 3917350
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
Mercado-Asis LB; Yanovski JA; Tracer HL; Chik CL; Cutler GB
J Clin Endocrinol Metab; 1997 Feb; 82(2):514-7. PubMed ID: 9024246
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment and Cushing's disease].
Luton JP; Ghnassia JP; Bricaire H
Sem Hop; 1977 Jun; 53(24):1476-9. PubMed ID: 197640
[TBL] [Abstract][Full Text] [Related]
16. Cyclical Cushing's disease and its successful control under sodium valproate.
Beckers A; Stevenaert A; Pirens G; Flandroy P; Sulon J; Hennen G
J Endocrinol Invest; 1990 Dec; 13(11):923-9. PubMed ID: 2090672
[TBL] [Abstract][Full Text] [Related]
17. [Neurotensin in Itsenko-Cushing disease].
Slavnov VN; Luchitskiĭ EV; Iakovlev AA; Komissarenko IV; Valueva GV
Probl Endokrinol (Mosk); 1984; 30(4):35-40. PubMed ID: 6382246
[TBL] [Abstract][Full Text] [Related]
18. The medical treatment of Cushing's syndrome.
Miller JW; Crapo L
Endocr Rev; 1993 Aug; 14(4):443-58. PubMed ID: 7693447
[No Abstract] [Full Text] [Related]
19. [Evaluation of the treatment of Cushing's syndrome using ketoconazole].
Conget JI; Halperin I; Vendrell J; Ferrer J; Martínez-Osaba MJ; Esmatjes E; Vilardell E
Med Clin (Barc); 1989 Nov; 93(14):531-4. PubMed ID: 2695699
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and biochemical remission of Itsenko-Cushing disease during parlodel treatment].
Marova EI; Butrova SA; Pronin VS
Sov Med; 1978 Jun; (6):91-4. PubMed ID: 354026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
